Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Tilarginine

Alternative Names: tilarginine
Latest Update: 2023-12-05
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: NOS Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Arginox
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Myocardial Infarction|Shock, Cardiogenic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
TRIUMPH Study

P3

Completed

Myocardial Infarction|Shock, Cardiogenic

2007-08-22

ARG-CS3-001

P3

Terminated

Myocardial Infarction|Shock, Cardiogenic

None

Recent News Events

Date

Type

Title

12/05/2023

PubMed

 Suppressive effect of nitric oxide synthase (NOS) inhibitor L-NMMA acetate on choroidal fibrosis in experimental myopic guinea pigs through the nitric oxide signaling pathway.

12/01/2023

PubMed

 An oral glucose tolerance test does not affect cerebral blood flow: role of NOS.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions